Discontinuation of Levemir products
Levemir is being discontinued, with stock due to run out in December 2026; switch patients in good time.
Showing: Guidance Everything, including news and events
Topics:Collective action & GPCContracts & fundingPCNs & neighbourhoodsVaccinations & screeningPrescribing & medicinesReferrals & hospital servicesPublic healthIT, data & cyber securityWorkforce & employmentCQC, regulation & governancePCSE & patient registrationFees & non-NHS workPremises & estatesWellbeing & supportBLMC news
Levemir is being discontinued, with stock due to run out in December 2026; switch patients in good time.
After coroners' reports, GPs are asked to remind patients with Addison's disease to carry their Steroid Emergency Card.
NICE recommends semaglutide injections to prevent heart attacks and strokes in eligible patients.
People released from places of detention will leave with a first repeat EPS prescription, from April 2026.
Public consultation until 7 June 2026 on a draft policy on hormones in children and young people's gender services.
Care leavers will get free NHS prescriptions, dental and eye care by the end of 2026.
Some ICBs are adding their own eligibility thresholds for GP prescribing of tirzepatide (Mounjaro).
Final NICE type 2 diabetes guidance recommends offering SGLT-2 inhibitors much earlier.
The RCGP comments on a Lancet review finding most reported statin side effects aren't caused by statins.
Cookies on this site. We’d like to use Google Analytics cookies to see which pages are used, so we can improve the site. They are not used for advertising.